Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Ultimovacs ASA

By efain on Fri, 10/29/2021 - 13:54
  • Read more about Ultimovacs ASA

AstraZeneca

By efain on Fri, 10/29/2021 - 12:53
  • Read more about AstraZeneca

Akero Therapeutics, Inc

By efain on Thu, 10/21/2021 - 12:08
  • Read more about Akero Therapeutics, Inc

GenSight Biologics

By efain on Thu, 10/21/2021 - 12:00
  • Read more about GenSight Biologics

Recursion Pharmaceuticals, Inc.

By efain on Thu, 10/21/2021 - 11:57
  • Read more about Recursion Pharmaceuticals, Inc.

Vasgene Therapeutics, Inc.

By efain on Thu, 09/16/2021 - 16:25
  • Read more about Vasgene Therapeutics, Inc.

ISA Therapeutics B.V.

By efain on Tue, 09/14/2021 - 16:05
  • Read more about ISA Therapeutics B.V.

Cara Therapeutics

By efain on Tue, 09/14/2021 - 16:01
  • Read more about Cara Therapeutics

Compassionate Use of Concizumab if You Have Haemophilia

  • Read more about Compassionate Use of Concizumab if You Have Haemophilia

SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer

  • Read more about SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 200
  • Page 201
  • Page 202
  • Page 203
  • Current page 204
  • Page 205
  • Page 206
  • Page 207
  • Page 208
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA